Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Radiotherapy as primary treatment for chemodectoma?].

D Verniers1, E Van Limbergen, J Leysen

  • 1Afdeling Radiotherapie, U.Z. St. Rafaël, Leuven.

Acta Oto-Rhino-Laryngologica Belgica
|January 1, 1990
PubMed
Summary

Chemodectomas, tumors of chemoreceptor bodies, can be diagnosed via CT scans. Radiotherapy offers a >90% local control rate for these slow-growing tumors, avoiding surgical morbidity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysis.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

Vaginal changes, sexual functioning and distress of women with locally advanced cervical cancer treated in the EMBRACE vaginal morbidity substudy.

Gynecologic oncology·2023
Same author

Brachytherapy treatment verification using gamma radiation from the internal treatment source combined with an imaging panel-a phantom study.

Physics in medicine and biology·2021
Same author

Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study.

Gynecologic oncology·2020
Same author

Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19].

Thrombosis research·2020
Same author

Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.

Thrombosis research·2019

Area of Science:

  • Oncology
  • Radiology
  • Neurosurgery

Background:

  • Chemodectomas are slow-growing tumors originating from chemoreceptor bodies.
  • Diagnosis relies on clinical presentation and advanced radiological imaging, such as contrast-enhanced CT scans.
  • CT imaging is crucial for assessing tumor size, extent, and potential bone destruction.

Observation:

  • Surgery is effective for small tympanic chemodectomas, with minimal complications.
  • Larger chemodectomas treated surgically have a high recurrence rate (>50%) and significant morbidity, including neurological deficits.
  • Radiotherapy presents a viable alternative treatment option for chemodectomas.

Findings:

  • This study confirms the efficacy of radiotherapy in managing chemodectomas.
  • Carefully planned radiotherapy with moderate doses (45-50 Gy over 5 weeks) achieves local control in over 90% of cases.
  • Radiotherapy avoids the high recurrence rates and neurological sequelae associated with surgical intervention for larger lesions.

Implications:

  • Radiotherapy is a highly effective and safe treatment modality for chemodectomas, particularly larger ones.
  • This approach minimizes the risk of local recurrence and neurological complications compared to surgery.
  • Optimized radiotherapy protocols can lead to excellent long-term outcomes for patients with chemodectomas.

Related Experiment Videos